Aktualitások a cardiovascularis kockázat értékelésében és a preventív terápiában a II. Magyar Terápiás Konszenzus Konferencia ajánlásaiban

Translated title of the contribution: New features in the cardiovascular risk estimation and in the preventiv therapy in the recommendations of the Second Hungarian Therapeutic Consensus Conference

Gyula Pados, István Karádi, György Paragh, László Halmy, György Jermendy, Károly Zámolyi, István Kiss

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The First Hungarian Therapeutic Consensus Conference took place on 3rd Nov. 2003 with the participation of 9 medical societies. Over the past 2 years the results of new major studies have been published and the American ATP III has also updated its guidelines issued in 2004. Based on the above proposals, the Second Hungarian Therapeutic Consensus Conference held on 3rd Nov. 2005 partly confirmed its earlier suggestions, but made some changes as well. Within the high risk category the Conference optionally created a very high risk group from those patients who - in addition to their cardiovascular disease - have either diabetes or metabolic syndrome or acut coronaria syndrome or who are chain smokers. We have included - as a complement - into the asymptomatic high risk category such newly emerging risk factors, one of which already in itself means high risk: ankle/arm index: ≤0.9, GFR <60 ml/min, microalbuminuria (30-300 mg), preclinic atherosclerosis (plaque). Besides, 4 other risk factors were also categorised such as Lp/ a (≥30mg/dl), CRP (≥3mg/l homocystein (≥12μmol), familiarity - atherogenic gene constellation, but only the presence of at least two of these verify high risk. In very high risk group the goals of 3.5 mmol /l and 1.8 mmol/l were determined as therapeutic option. The goal in obese patients - expressed earlier only in BMl - can now be equally determined by the abdominal circumference (94 cm for men, 80 cm for women respectively). ACE inhibitors were recommended earlier as a preventive therapy in case of dysfunction of the left ventricle, while at present they are suggested or all patients with cardiovascular disease. In the recent recommendations guidelines related to nutrition, smoking, exercise have also been included.

Translated title of the contributionNew features in the cardiovascular risk estimation and in the preventiv therapy in the recommendations of the Second Hungarian Therapeutic Consensus Conference
Original languageHungarian
Pages (from-to)1299-1306
Number of pages8
JournalOrvosi hetilap
Volume147
Issue number28
Publication statusPublished - Jul 16 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'New features in the cardiovascular risk estimation and in the preventiv therapy in the recommendations of the Second Hungarian Therapeutic Consensus Conference'. Together they form a unique fingerprint.

  • Cite this